Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;44(6):468-480.
doi: 10.5535/arm.20100. Epub 2020 Dec 31.

Exercise Program Improves Functional Capacity and Quality of Life in Uncorrected Atrial Septal Defect-Associated Pulmonary Arterial Hypertension: A Randomized-Control Pilot Study

Affiliations

Exercise Program Improves Functional Capacity and Quality of Life in Uncorrected Atrial Septal Defect-Associated Pulmonary Arterial Hypertension: A Randomized-Control Pilot Study

Annis Rakhmawati et al. Ann Rehabil Med. 2020 Dec.

Abstract

Objective: To assess the effect of combined hospital and home-based exercise programs on functional capacity and quality of life (QoL) among uncorrected atrial septal defect-associated pulmonary arterial hypertension (ASD-PAH) patients.

Methods: This study was a randomized controlled trial with uncorrected ASD-PAH patients as the subjects. They were allocated randomly into control and exercise groups. Exercise group subjects performed hospital and home-based exercise programs, completing baseline 6-minute walking test (6MWT) and EQ-5D-3L QoL test (Utility Index and EQ-VAS scores), and were followed up for 12 weeks. The primary outcomes were 6MWT distance and EQ-5D-3L score at week 12. The N-terminal pro B-type natriuretic peptide (NT-proBNP) level was also assessed. A repeated-measure ANOVA was performed to detect endpoint differences over time.

Results: The exercise group contained 20 subjects and control group contained 19. In total, 19 exercise group subjects and 16 control group subjects completed the protocol. The 6MWT distance, Utility Index score, and EQ-VAS score incrementally improved significantly in the exercise group from baseline until week 12, with mean differences of 76.7 m (p<0.001), 0.137 (p<0.001) and 15.5 (p<0.001), respectively. Compared with the control group, the exercise group had significantly increased 6MWT distance and utility index score at week 12. The EQ-VAS score increased in the exercise group at week 12. The NT-proBNP level decreased at week 12 in the exercise group.

Conclusion: Combined hospital and home-based exercise program added to PAH-targeted therapy, improving functional capacity and QoL in uncorrected ASD-PAH patients.

Keywords: Atrial; Exercise therapy; Heart septal defects; Physical functional performance; Pulmonary arterial hypertension; Quality of life.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest relevant to this article were reported.

Figures

Fig. 1.
Fig. 1.
The schematic flowchart of the study.
Fig. 2.
Fig. 2.
The CONSORT diagram of subject enrollment and study. ASD, atrial septal defect ; PAH, pulmonary arterial hypertension.
Fig. 3.
Fig. 3.
The significant improvement of functional capacity from baseline to week 12 follow-up in the exercise group. 6MWT, 6-minute walking test.
Fig. 4.
Fig. 4.
The significant incremental improvement of quality of life by Utility Index score from baseline to week 12 follow-up in the exercise group.
Fig. 5.
Fig. 5.
The significant incremental improvement of quality of life by EQ-VAS (EuroQol visual analog scale) score from baseline to week 12 follow-up in the exercise group.
Fig. 6.
Fig. 6.
The N-terminal pro B-type natriuretic peptide (NTproBNP) level at baseline and week 12 follow-up in the control group (2,187.2±594.2 pg/mL vs. 2,225.4±576.4 pg/mL; p=0.777) and the exercise group (3,390.4±1,325.4 pg/mL vs. 3,113.6±1,310.8 pg/mL; p=0.232) did not significantly change. In the exercise group, the NT-proBNP level tended to decrease with mean absolute changes of -276.8 pg/mL.

References

    1. Lilly SL. Pathophysiology of heart disease: a collaborative project of medical students and faculty. 5th Ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2011.
    1. Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT) Eur Heart J. 2016;37:67–119. - PubMed
    1. D’Alto M, Merola A, Dimopoulos K. Pulmonary hypertension related to congenital heart disease: a comprehensive review. Glob Cardiol Sci Pract. 2015;2015:42.
    1. Dinarti LK, Hartopo AB, Kusuma AD, Satwiko MG, Hadwiono MR, Pradana AD, et al. The COngenital HeARt Disease in adult and Pulmonary Hypertension (COHARD-PH) registry: a descriptive study from single-center hospital registry of adult congenital heart disease and pulmonary hypertension in Indonesia. BMC Cardiovasc Disord. 2020;20:163. - PMC - PubMed
    1. Vijarnsorn C, Durongpisitkul K, Chungsomprasong P, Bositthipichet D, Ketsara S, Titaram Y, et al. Contemporary survival of patients with pulmonary arterial hypertension and congenital systemic to pulmonary shunts. PLoS One. 2018;13:e0195092. - PMC - PubMed